UB Paderborn / Katalog / Suche / Details

Ergebnis 23 von 90

Current opinion in investigational drugs (London, England : 2000), 2006-02, Vol.7 (2), p.180

2006

Autor(en) / Beteiligte

Titel

SCV-07 (SciClone Pharmaceuticals/Verta)

Ist Teil von

Current opinion in investigational drugs (London, England : 2000), 2006-02, Vol.7 (2), p.180

Ort / Verlag

England

Erscheinungsjahr

2006

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

SciClone Pharmaceuticals and Verta are developing SCV-07, the lead in a series of immnunostimulants from Verta, for the potential treatment of tuberculosis and hepatitis C virus infection. Phase II clinical trials of the compound are ongoing.

Format: –
Schlagworte: Adjuvants, Immunologic - administration & dosage, Adjuvants, Immunologic - pharmacokinetics, Adjuvants, Immunologic - therapeutic use, Animals, Anti-Bacterial Agents - administration & dosage, Anti-Bacterial Agents - pharmacokinetics, Anti-Bacterial Agents - therapeutic use, Antiviral Agents - administration & dosage, Antiviral Agents - pharmacokinetics, Antiviral Agents - therapeutic use, Clinical Trials as Topic, Dipeptides - administration & dosage, Dipeptides - pharmacokinetics, Dipeptides - therapeutic use, Drug Administration Schedule, Drug Evaluation, Preclinical, Hepatitis C, Chronic - drug therapy, Humans, Injections, Intramuscular, Lassa virus - drug effects, Mycobacterium tuberculosis - drug effects, Mycobacterium tuberculosis - growth & development, Papillomaviridae - drug effects, Spleen - cytology, Spleen - drug effects, Thymus Gland - cytology, Thymus Gland - drug effects, Tuberculosis - drug therapy

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX